Sign in

CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Elicio Therapeutics, Inc.

Sign in to watch
Ticker
ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113430072
Phone
(857) 209-0050
Business address
451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
Former names
Angion Biomedica Corp.
  1. UPLOAD Other SEC-generated Letter
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. SC 13G Stake Amended Statement of Ownership
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. S-3 Offering Registration Statement
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13D Stake Beneficial Ownership Report
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. SC 13G Stake Amended Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 8-K Event Executive or director change
  20. SC 13G Stake Amended Statement of Ownership

Page 14 of 20 · 384 filings